GlobalData on MSN1d
Vaxxas completes enrolment in Phase I H7N9 bird flu vaccine trial
The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.
Vaxxas Completes Enrollment for Largest Clinical Trial of High-Density Microarray Patch (HD-MAP) For Vaccine Delivery
Vaxxas, a clinical-stage biotechnology company, today announced it has completed enrollment for its Phase I clinical trial of a vaccine against an avian influenza A (H7N9) virus with pandemic ...
Cure Today10d
Personalized Kidney Cancer Vaccine May Help Prevent Future Relapse
In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.
EQS-News: Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
EQS-News: GeoVax, Inc. / Key word (s): Financial Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification 19.02.2025 / 15:04 CET/CEST The issuer is solely responsible for the ...
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
Cure Today3d
Cancer Vaccine Elicits Promising Responses in Renal Cell Carcinoma
All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.